Table 2 Outcomes measures at baseline, follow-up (4 months) and change from baseline (n = 12)
From: Platelet-rich plasma (PRP) therapy for knee arthritis: a feasibility study in primary care
Outcome | Baseline Mean (SD) and range | Follow-up Mean (SD) and range | Mean change from baseline (95% CI) |
|---|---|---|---|
*Total pain score | 45.3 (17.38) 25.0–77.3 | 16.3 (17.28) 0–63.6 | − 29.0 (− 39.1, − 18.9) |
*Constant pain subscore | 35.0 (27.96) 0–75.0 | 6.3 (16.39) 0–55.0 | − 28.8 (−43.7, − 13.8) |
*Intermittent pain subscore | 53.8 (10.87) 41.7–79.2 | 24.7 (21.06) 0–70.8 | − 29.2 (−41.5, − 16.8) |
#EQ-5D-3L | 0.45 (0.19) 0.08–0.62 | 0.77 (0.25) 0.08–1.00 | + 0.32 (0.18, 0.46) |
#EQ-VAS | 63.4 (9.10) 50–80 | 74.3 (17.72) 40–100 | + 10.8 (2.5, 19.2) |